NanoVibronix develops innovative ultrasound therapy devices based on its proprietary therapeutic ultrasound technology.
Our products employ small, disposable transducers that transmit low frequency, low intensity ultrasound acoustic waves. These devices address a range of clinical applications helping eliminate pain, repair and regenerate tissue in musculoskeletal / vascular structures and decrease
bioﬁlm formation on urinary catheters thus reducing risk of Catheter Associated Urinary Tract Infections (CAUTI).
Due to their effectiveness, size and ease of use, these products help promote patient independence and enable cost-effective home-based care.
For more information about our ultrasound therapy devices, make sure to browse our site to read more about us.
NanoVibronix UroShield® Receives U.S. Food and Drug Administration Authorization for Entry into the U.S.
FDA Clears Path for Patient Access to UroShield Device for the duration of the Covid-19 pandemic
The U.S. Food and Drug Administration (“FDA”) has decided to exercise its Enforcement Discretion to allow distribution of the UroShield device in the United States. According to the FDA, “UroShield® device can use Intended Use Code (IUC) 081.006: Enforcement discretion per final guidance, and FDA product code QMK (extracorporeal acoustic wave generating accessory to urological indwelling catheter for use during the COVID-19 pandemic)”.
UroShield® is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm on indwelling urinary catheters and increase antibiotic efficacy, ultimately reducing the incidence of catheter-associated urinary tract infections (“CAUTI”). UroShield® is also intended to decrease pain and discomfort associated with urinary catheter use. Read more…
Targeted therapeutic ultrasound – that uniquely generates and delivers localized, low frequency, low intensity therapeutic ultrasound through a self-adhering patch, placed on or next to the treated area.
Patch based ultrasound device intended to facilitate expedited tissue regeneration and wound healing by increase of local capillary perfusion and tissue oxygenation.
Ultrasound based device that dramatically reduces bacterial colonization and bioﬁlm on urinary catheters, thereby reducing risk for catheter associated urinary tract infection (CAUTI)